The study population included a Moroccan and Turkish patient group and a non-Turkish/Moroccan patient group. These patients were diagnosed with breast cancer between January 2007 and December 2012 in six hospitals in the Utrecht region and in Amsterdam, the Netherlands.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.